Noradrenergic targets for the treatment of alcohol use disorder (original) (raw)

• Abercrombie ED, Keller RW, JR. & Zigmond, M. J. (1988) Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience 27(3):897–904. https://doi.org/10.1016/0306-4522(88)90192-3
• Adinoff B (1994) Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. Alcohol Clin Exp Res 18(4):873–878. https://doi.org/10.1111/j.1530-0277.1994.tb00053.x
  Article CAS PubMed Google Scholar
• Aghajanian GK, Vandermaelen CP (1982) Alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science 215(4538):1394–1396. https://doi.org/10.1126/science.6278591
  Article CAS PubMed Google Scholar
• Ahlenius S, Carlsson A, Engel J, Svensson T, Sodersten P (1973) Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man. Clin Pharmacol Ther 14(4part1):586–591. https://doi.org/10.1002/cpt1973144part1586
  Article CAS PubMed Google Scholar
• Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Phys 153:586–600
  CAS Google Scholar
• Akduman B, Crawford ED (2001) Terazosin, doxazosin, and prazosin: current clinical experience. Urology 58(6):49–54. https://doi.org/10.1016/S0090-4295(01)01302-4
  Article CAS PubMed Google Scholar
• Alonso G, Szafarczyk A, Balmefrezol M, Assenmacher I (1986) Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats. Brain Res 397(2):297–307. https://doi.org/10.1016/0006-8993(86)90631-1
  Article CAS PubMed Google Scholar
• Amit Z, Brown ZW, Levitan DE, Ogren SO (1977) Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition. Arch Int Pharmacodyn Ther 230(1):65–75
  CAS PubMed Google Scholar
• Bailly D, Servant D, Blandin N, Beuscart R, Parquet PJ (1992) Effects of beta-blocking drugs in alcohol withdrawal: a double-blind comparative study with propranolol and diazepam. Biomed Pharmacother 46(9):419–424. https://doi.org/10.1016/0753-3322(92)90047-B
  Article CAS PubMed Google Scholar
• Becker HC (2012) Effects of alcohol dependence and withdrawal on stress responsiveness and alcohol consumption. Alcohol Res 34(4):448–458
  PubMed PubMed Central Google Scholar
• Begleiter H (1974) Propranolol and alcohol consumption in the rat. Am J Drug Alcohol Abuse 1(1):107–110. https://doi.org/10.3109/00952997409031911
  Article CAS PubMed Google Scholar
• Berlan M, Montastruc JL, Lafontan M (1992) Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy. Trends Pharmacol Sci 13(7):277–282. https://doi.org/10.1016/0165-6147(92)90085-K
  Article CAS PubMed Google Scholar
• Berggren U, Berglund K, Eriksson M, Fahlke C, Zachrisson O, Balldin J (2003) Subnormal alpha-2-adrenoceptor-mediated sedation during 6 months of sobriety in male type 1 alcohol-dependent subjects. Alcohol Alcohol 38:321–6
• Berggren U, Eriksson M, Fahlke C, Sundkler A, Balldin J (2002) Extremely long recovery time for the sedative effect of clonidine in male type 1 alcohol-dependent subjects in full sustained remission. Alcohol 28:181–7
• Bjorkqvist SE (1975) Clonidine in alcohol withdrawal. Acta Psychiatr Scand 52(4):256–263. https://doi.org/10.1111/j.1600-0447.1975.tb00041.x
  Article CAS PubMed Google Scholar
• Corrodi H, Fuxe K, Hokfelt T (1966) The effect of ethanol on the activity of central catecholamine neurones in rat brain. J Pharm Pharmacol 18(12):821–823. https://doi.org/10.1111/j.2042-7158.1966.tb07817.x
  Article CAS PubMed Google Scholar
• Doxey JC, Roach AG, Smith CF (1983) Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol 78(3):489–505. https://doi.org/10.1111/j.1476-5381.1983.tb08809.x
  Article CAS PubMed PubMed Central Google Scholar
• Doxey JC, Lane AC, Roach AG, Virdee NK (1984) Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn Schmiedeberg's Arch Pharmacol 325(2):136–144. https://doi.org/10.1007/BF00506193
  Article CAS Google Scholar
• Durcan MJ, Lister RG, Linnoila M (1989a) Behavioral effects of alpha 2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice. Psychopharmacology 97(2):189–193. https://doi.org/10.1007/BF00442248
  Article CAS PubMed Google Scholar
• Durcan MJ, Lister RG, Linnoila M (1989b) Interactions of alpha 2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test. Neuropharmacology 28(3):275–281. https://doi.org/10.1016/0028-3908(89)90104-4
  Article CAS PubMed Google Scholar
• Durcan MJ, Wozniak KM, Lister RG, Linnoila M (1989c) Attenuation of hypothermic effects of ethanol by alpha 2-adrenoceptor blockers. Eur J Pharmacol 166(3):381–386. https://doi.org/10.1016/0014-2999(89)90349-X
  Article CAS PubMed Google Scholar
• Egli RE, Winder DG (2003) Dorsal and ventral distribution of excitable and synaptic properties of neurons of the bed nucleus of the stria terminalis. J Neurophysiol 90(1):405–414. https://doi.org/10.1152/jn.00228.2003
  Article PubMed Google Scholar
• Egli RE, Kash TL, Choo K, Savchenko V, Matthews RT, Blakely RD, Winder DG (2005) Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology 30(4):657–668. https://doi.org/10.1038/sj.npp.1300639
  Article CAS PubMed Google Scholar
• Fitzgerald PJ (2013) Elevated norepinephrine may be a unifying etiological factor in the abuse of a broad range of substances: alcohol, nicotine, marijuana, heroin, cocaine, and caffeine. Subst Abuse 7:171–183. https://doi.org/10.4137/SART.S13019
  PubMed PubMed Central Google Scholar
• Fox HC, Bergquist KL, Hong KI, Sinha R (2007) Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcohol Clin Exp Res 31(3):395–403. https://doi.org/10.1111/j.1530-0277.2006.00320.x
  Article PubMed Google Scholar
• Fox HC, Anderson GM, Tuit K, Hansen J, Kimmerling A, Siedlarz KM, Morgan PT, Sinha R (2012) Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. Alcohol Clin Exp Res 36(2):351–360. https://doi.org/10.1111/j.1530-0277.2011.01628.x
  Article CAS PubMed Google Scholar
• Fredriksson I, Jayaram-Lindstrom N, Wirf M, Nylander E, Nystrom E, Jardemark K, Steensland P (2015) Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings. Neuropsychopharmacology 40(5):1130–1140. https://doi.org/10.1038/npp.2014.294
  Article CAS PubMed Google Scholar
• Froehlich JC, Hausauer B, Fischer S, Wise B, Rasmussen DD (2015) Prazosin reduces alcohol intake in an animal model of alcohol relapse. Alcohol Clin Exp Res 39(8):1538–1546. https://doi.org/10.1111/acer.12789
  Article CAS PubMed PubMed Central Google Scholar
• Funk D, Coen K, Tamadon S, LI Z, Loughlin A, Le AD (2016) Effects of prazosin and doxazosin on yohimbine-induced reinstatement of alcohol seeking in rats. Psychopharmacology 233(11):2197–2207. https://doi.org/10.1007/s00213-016-4273-2
  Article CAS PubMed Google Scholar
• Gilpin NW, Koob GF (2010) Effects of beta-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats. Psychopharmacology 212(3):431–439. https://doi.org/10.1007/s00213-010-1967-8
  Article CAS PubMed PubMed Central Google Scholar
• Giovannitti, J. A. Jr., Thoms, S. M. & Crawford, J. J. 2015. Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth Prog, 62**,** 31–39, 1, DOI: https://doi.org/10.2344/0003-3006-62.1.31
• Gold MS, Pottash AC, Sweeney DR, Kleber HD (1980) Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment. JAMA 243(4):343–346. https://doi.org/10.1001/jama.1980.03300300021018
  Article CAS PubMed Google Scholar
• Gross G, Hanft G, Mehdorn HM (1989) Demonstration of alpha 1A- and alpha 1B-adrenoceptor binding sites in human brain tissue. Eur J Pharmacol 169(2-3):325–328. https://doi.org/10.1016/0014-2999(89)90032-0
  Article CAS PubMed Google Scholar
• Haass-Koffler CL, Leggio L, Kenna GA (2014) Pharmacological approaches to reducing craving in patients with alcohol use disorders. CNS Drugs 28(4):343–360. https://doi.org/10.1007/s40263-014-0149-3
  Article CAS PubMed PubMed Central Google Scholar
• Haass-Koffler CL, Leggio L, Davidson D, Swift RM (2015) Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study. Alcohol Clin Exp Res 39(4):594–602. https://doi.org/10.1111/acer.12658
  Article CAS PubMed PubMed Central Google Scholar
• Haass-Koffler CL, Akhlaghi F, Swift RM, Leggio L (2017a) Altering ethanol pharmacokinetics to treat alcohol use disorder: can you teach an old dog new tricks? J Psychopharmacol 31(7):812–818. https://doi.org/10.1177/0269881116684338
  Article CAS PubMed PubMed Central Google Scholar
• Haass-Koffler CL, Akhlaghi F, Swift RM, Leggio L (2017b) Altering ethanol pharmacokinetics to treat alcohol use disorder: can you teach an old dog new tricks? J Psychopharmacol 269881116684338
• Haass-Koffler CL, Goodyear K, Zywiak WH, Magill M, Eltinge SE, Wallace PM, Long VM, Jayaram-Lindstrom N, Swift RM, Kenna GA, Leggio L (2017c) Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin. Drug Alcohol Depend 177:23–28. https://doi.org/10.1016/j.drugalcdep.2017.03.016
  Article CAS PubMed Google Scholar
• Hawley RJ, Major LF, Schulman EA, Lake CR (1981) CSF levels of norepinephrine during alcohol withdrawal. Arch Neurol 38(5):289–292. https://doi.org/10.1001/archneur.1981.00510050055008
  Article CAS PubMed Google Scholar
• Hofner K, Jonas U (2002) Alfuzosin: a clinically uroselective alpha1-blocker. World J Urol 19(6):405–412. https://doi.org/10.1007/s00345-002-0244-9
  Article CAS Google Scholar
• Horwitz RI, Gottlieb LD, Kraus ML (1989) The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. Arch Intern Med 149(5):1089–1093. https://doi.org/10.1001/archinte.1989.00390050075015
  Article CAS PubMed Google Scholar
• Kash TL (2012) The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse. Alcohol 46(4):303–308. https://doi.org/10.1016/j.alcohol.2011.12.004
  Article CAS PubMed PubMed Central Google Scholar
• Kaye B, Cussans NJ, Faulkner JK, Stopher DA, Reid JL (1986) The metabolism and kinetics of doxazosin in man, mouse, rat and dog. Br J Clin Pharmacol 21(Suppl 1):19S–25S. https://doi.org/10.1111/j.1365-2125.1986.tb02849.x
  Article CAS PubMed PubMed Central Google Scholar
• Keaney F, Strang J, Gossop M, Marshall EJ, Farrell M, Welch S, Hahn B, Gonzalez A (2001) A double-blind randomized placebo-controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide. Alcohol Alcohol 36(5):426–430. https://doi.org/10.1093/alcalc/36.5.426
  Article CAS PubMed Google Scholar
• Kenna GA, Haass-Koffler CL, Zywiak WH, Edwards SM, Brickley MB, Swift RM, Leggio L (2016) Role of the alpha1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial. Addict Biol 21(4):904–914. https://doi.org/10.1111/adb.12275
  Article CAS PubMed Google Scholar
• Kent JM, Mathew SJ, Gorman JM (2002) Molecular targets in the treatment of anxiety. Biol Psychiatry 52(10):1008–1030. https://doi.org/10.1016/S0006-3223(02)01672-4
  Article CAS PubMed Google Scholar
• Koob GF (2008) A role for brain stress systems in addiction. Neuron 59(1):11–34. https://doi.org/10.1016/j.neuron.2008.06.012
  Article CAS PubMed PubMed Central Google Scholar
• Koob GF (2009) Brain stress systems in the amygdala and addiction. Brain Res 1293:61–75. https://doi.org/10.1016/j.brainres.2009.03.038
  Article CAS PubMed PubMed Central Google Scholar
• Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164(8):1149–1159. https://doi.org/10.1176/appi.ajp.2007.05030503
  Article PubMed PubMed Central Google Scholar
• Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278(5335):52–58. https://doi.org/10.1126/science.278.5335.52
  Article CAS PubMed Google Scholar
• Koob GF, Rassnick S, Heinrichs S, Weiss F (1994) Alcohol, the reward system and dependence. EXS 71:103–14
• Kovacs GL, Soroncz M, Tegyei I (2002) Plasma catecholamines in ethanol tolerance and withdrawal in mice. Eur J Pharmacol 448(2-3):151–156. https://doi.org/10.1016/S0014-2999(02)01939-8
  Article CAS PubMed Google Scholar
• Kreek MJ, Koob GF (1998) Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51(1-2):23–47. https://doi.org/10.1016/S0376-8716(98)00064-7
  Article CAS PubMed Google Scholar
• Langer SZ (1980) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32(4):337–362
  CAS PubMed Google Scholar
• Le AD, Harding S, Juzytsch W, Funk D, Shaham Y (2005) Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology 179(2):366–373. https://doi.org/10.1007/s00213-004-2036-y
  Article CAS PubMed Google Scholar
• Le AD, Funk D, Juzytsch W, Coen K, Navarre BM, Cifani C, Shaham Y (2011) Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats. Psychopharmacology 218(1):89–99. https://doi.org/10.1007/s00213-011-2178-7
  Article CAS PubMed PubMed Central Google Scholar
• Li TK, Lumeng L, Mcbride WJ, Waller MB (1979) Progress toward a voluntary oral consumption model of alcoholism. Drug Alcohol Depend 4(1-2):45–60
  Article CAS PubMed Google Scholar
• Lister RG, Durcan MJ, Nutt DJ, Linnoila M (1989) Attenuation of ethanol intoxication by alpha-2 adrenoceptor antagonists. Life Sci 44(2):111–119. https://doi.org/10.1016/0024-3205(89)90528-6
  Article CAS PubMed Google Scholar
• Litten RZ, Bradley AM, Moss HB (2010) Alcohol biomarkers in applied settings: recent advances and future research opportunities. Alcohol Clin Exp Res 34(6):955–967. https://doi.org/10.1111/j.1530-0277.2010.01170.x
  Article CAS PubMed Google Scholar
• Mao L, Abdel-Rahman AA (1996) Synergistic behavioral interaction between ethanol and clonidine in rats: role of alpha-2 adrenoceptors. J Pharmacol Exp Ther 279(2):443–449
  CAS PubMed Google Scholar
• Marinelli PW, Funk D, Juzytsch W, Harding S, Rice KC, Shaham Y, Le AD (2007) The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology 195(3):345–355. https://doi.org/10.1007/s00213-007-0905-x
  Article CAS PubMed Google Scholar
• Mccall JG, Siuda ER, Bhatti DL, Lawson LA, Mcelligott ZA, Stuber GD, Bruchas MR (2017) Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior. Elife 6
• Mcdougle CJ, Krystal JH, Price LH, Heninger GR, Charney DS (1995) Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine. Psychopharmacology 118(2):127–135. https://doi.org/10.1007/BF02245830
  Article CAS PubMed Google Scholar
• Mcelligott ZA, Klug JR, Nobis WP, Patel S, Grueter BA, Kash TL, Winder DG (2010) Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress. Proc Natl Acad Sci U S A 107(5):2271–2276. https://doi.org/10.1073/pnas.0905568107
  Article CAS PubMed PubMed Central Google Scholar
• Mcleod SD, Cairncross KD (1995) Preliminary evidence of a synergistic alpha 1- and beta 1-adrenoceptor regulation of rat pineal hydroxyindole-O-methyltransferase. Gen Comp Endocrinol 97(3):283–288. https://doi.org/10.1006/gcen.1995.1028
  Article CAS PubMed Google Scholar
• Michel MC, Schafers RF, Goepel M (2000) Alpha-blockers and lower urinary tract function: more than smooth muscle relaxation? BJU Int 86(Suppl 2):23–28; discussion 28-30. https://doi.org/10.1046/j.1464-410X.2000.00094.x
  Article CAS PubMed Google Scholar
• Mirijello A, D'angelo C, Ferrulli A, Vassallo G, Antonelli M, Caputo F, Leggio L, Gasbarrini A, ADDOLORATO G (2015) Identification and management of alcohol withdrawal syndrome. Drugs 75(4):353–365. https://doi.org/10.1007/s40265-015-0358-1
  Article CAS PubMed PubMed Central Google Scholar
• O'neil ML, Beckwith LE, Kincaid CL, Rasmussen DD (2013) The alpha1-adrenergic receptor antagonist, doxazosin, reduces alcohol drinking in alcohol-preferring (P) rats. Alcohol Clin Exp Res 37(2):202–212. https://doi.org/10.1111/j.1530-0277.2012.01884.x
  Article PubMed Google Scholar
• Patkar AA, Gopalakrishnan R, Naik PC, Murray HW, Vergare MJ, Marsden CA (2003) Changes in plasma noradrenaline and serotonin levels and craving during alcohol withdrawal. Alcohol Alcohol 38(3):224–231. https://doi.org/10.1093/alcalc/agg055
  Article CAS PubMed Google Scholar
• Petrakis IL, Desai N, Gueorguieva R, Arias A, O'brien E, Jane JS, Sevarino K, Southwick S, Ralevski E (2016) Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial. Alcohol Clin Exp Res 40(1):178–186. https://doi.org/10.1111/acer.12926
  Article CAS PubMed Google Scholar
• Pichot C, Ghignone M, Quintin L (2012) Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting? J Intensive Care Med 27(4):219–237. https://doi.org/10.1177/0885066610396815
  Article CAS PubMed Google Scholar
• Qin K, Sethi PR, Lambert NA (2008) Abundance and stability of complexes containing inactive G protein-coupled receptors and G proteins. FASEB J 22(8):2920–2927. https://doi.org/10.1096/fj.08-105775
  Article CAS PubMed PubMed Central Google Scholar
• Raskind MA, Peterson K, Williams T, Hoff DJ, Hart K, Holmes H, Homas D, Hill J, Daniels C, Calohan J, Millard SP, Rohde K, O'connell J, Pritzl D, Feiszli K, Petrie EC, Gross C, Mayer CL, Freed MC, Engel C, Peskind ER (2013) A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. Am J Psychiatry 170(9):1003–1010. https://doi.org/10.1176/appi.ajp.2013.12081133
  Article PubMed Google Scholar
• Raskind, M. A., Millard, S. P., Petrie, E. C., Peterson, K., Williams, T., Hoff, D. J., Hart, K., Holmes, H., Hill, J., Daniels, C., Hendrickson, R. & Peskind, E. R. 2016. Higher pretreatment blood pressure is associated with greater posttraumatic stress disorder symptom reduction in soldiers treated with prazosin. Biol Psychiatry
• Rasmussen DD, Alexander LL, Raskind MA, Froehlich JC (2009) The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats. Alcohol Clin Exp Res 33(2):264–272. https://doi.org/10.1111/j.1530-0277.2008.00829.x
  Article CAS PubMed Google Scholar
• Rasmussen DD, Alexander L, Malone J, Federoff D, Froehlich JC (2014a) The alpha2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats. Alcohol 48(6):543–549. https://doi.org/10.1016/j.alcohol.2014.07.002
  Article CAS PubMed PubMed Central Google Scholar
• Rasmussen DD, Beckwith LE, Kincaid CL, Froehlich JC (2014b) Combining the alpha1 -adrenergic receptor antagonist, prazosin, with the beta-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone. Alcohol Clin Exp Res 38(6):1532–1539. https://doi.org/10.1111/acer.12441
  Article CAS PubMed PubMed Central Google Scholar
• Reid JL (1986) Alpha-adrenergic receptors and blood pressure control. Am J Cardiol 57(9):6E–12E. https://doi.org/10.1016/0002-9149(86)90716-2
  Article CAS PubMed Google Scholar
• Riihioja P, Jaatinen P, Oksanen H, Haapalinna A, Heinonen E, Hervonen A (1997) Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat. Alcohol Clin Exp Res 21(5):804–808. https://doi.org/10.1111/j.1530-0277.1997.tb03843.x
  Article CAS PubMed Google Scholar
• Rosenbaum DM, Rasmussen SG, Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459(7245):356–363. https://doi.org/10.1038/nature08144
  Article CAS PubMed PubMed Central Google Scholar
• Saitz R (2017) Should Benzodiazepines Be Used to Treat Anxiety in People With Substance Use Disorders? Contentious Debate With Similar Conclusions. J Addict Med 11:83. https://doi.org/10.1007/s00213-018-4843-6
• Sarnyai Z, Shaham Y, Heinrichs SC (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53(2):209–243
  CAS PubMed Google Scholar
• Sica DA (2005) Alpha1-adrenergic blockers: current usage considerations. J Clin Hypertens 7(12):757–762. https://doi.org/10.1111/j.1524-6175.2005.05300.x
  Article CAS Google Scholar
• Silberman Y, Ariwodola OJ, Weiner JL (2012) beta1-adrenoceptor activation is required for ethanol enhancement of lateral paracapsular GABAergic synapses in the rat basolateral amygdala. J Pharmacol Exp Ther 343(2):451–459. https://doi.org/10.1124/jpet.112.196022
  Article CAS PubMed PubMed Central Google Scholar
• Simms JA, Haass-Koffler CL, Bito-Onon J, LI R, Bartlett SE (2012) Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking. Neuropsychopharmacology 37(4):906–918. https://doi.org/10.1038/npp.2011.268
  Article CAS PubMed Google Scholar
• Simpson TL, Saxon AJ, Meredith CW, Malte CA, Mcbride B, Ferguson LC, Gross CA, Hart KL, Raskind M (2009) A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcohol Clin Exp Res 33(2):255–263. https://doi.org/10.1111/j.1530-0277.2008.00807.x
  Article CAS PubMed Google Scholar
• Simpson TL, Malte CA, Dietel B, Tell D, Pocock I, Lyons R, Varon D, Raskind M, Saxon AJ (2015) A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res 39(5):808–817. https://doi.org/10.1111/acer.12703
  Article CAS PubMed PubMed Central Google Scholar
• Socaransky SM, Aragon CM, Rusk I, Amit Z, Ogren SO (1985) Norepinephrine turnover and voluntary consumption of ethanol in the rat. Alcohol 2(2):339–342. https://doi.org/10.1016/0741-8329(85)90071-0
  Article CAS PubMed Google Scholar
• Soyka M, Muller CA (2017) Pharmacotherapy of alcoholism - an update on approved and off-label medications. Expert Opin Pharmacother 18(12):1187–1199. https://doi.org/10.1080/14656566.2017.1349098
  Article CAS PubMed Google Scholar
• Strahlendorf HK, Strahlendorf JC (1983) Ethanol suppression of locus coeruleus neurons: relevancy to the fetal alcohol syndrome. Neurobehav Toxicol Teratol 5(2):221–224
  CAS PubMed Google Scholar
• Swift R, Oslin DW, Alexander M, Forman R (2011) Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol Drugs 72(6):1012–1018. https://doi.org/10.15288/jsad.2011.72.1012
  Article PubMed Google Scholar
• Taksande BG, Kotagale NR, Patel MR, Shelkar GP, Ugale RR, Chopde CT (2010) Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. Eur J Pharmacol 637(1-3):89–101. https://doi.org/10.1016/j.ejphar.2010.03.058
  Article CAS PubMed Google Scholar
• Thiele TE, Cubero I, Van Dijk G, Mediavilla C, Bernstein IL (2000) Ethanol-induced c-fos expression in catecholamine- and neuropeptide Y-producing neurons in rat brainstem. Alcohol Clin Exp Res 24(6):802–809. https://doi.org/10.1111/j.1530-0277.2000.tb02059.x
  Article CAS PubMed Google Scholar
• Trovero F, David S, Bernard P, Puech A, Bizot JC, Tassin JP (2016) The combination of marketed antagonists of alpha1b-adrenergic and 5-HT2A receptors inhibits behavioral sensitization and preference to alcohol in mice: a promising approach for the treatment of alcohol dependence. PLoS One 11(3):e0151242. https://doi.org/10.1371/journal.pone.0151242
  Article PubMed PubMed Central Google Scholar
• Trzaskowska E, Pucilowski O, Dyr W, Kostowski W, Hauptmann M (1986) Suppression of ethanol tolerance and dependence in rats treated with DSP-4, a noradrenergic neurotoxin. Drug Alcohol Depend 18(4):349–353. https://doi.org/10.1016/0376-8716(86)90098-0
  Article CAS PubMed Google Scholar
• Umhau JC, Schwandt ML, Usala J, Geyer C, Singley E, George DT, Heilig M (2011) Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 36(6):1178–1186. https://doi.org/10.1038/npp.2010.253
  Article CAS PubMed PubMed Central Google Scholar
• Van Bockstaele EJ, Reyes BA, Valentino RJ (2010) The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse. Brain Res 1314:162–74
• Walker BM, Rasmussen DD, Raskind MA, Koob GF (2008) alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 42(2):91–97. https://doi.org/10.1016/j.alcohol.2007.12.002
  Article CAS PubMed PubMed Central Google Scholar
• West CH, Boss-Williams KA, Ritchie JC, Weiss JM (2016) Reprint of: Locus coeruleus neuronal activity determines proclivity to consume alcohol in a selectively-bred line of rats that readily consumes alcohol. Alcohol, 50, 91–105
• Wilcox, C. 2017. Might diastolic blood pressure indicate a subtype of alcohol use disorder? [online]. NEJM watch. Available: http://www.jwatch.org/na44488/2017/07/07/might-diastolic-blood-pressure-indicate-subtype-alcohol?query=etoc_jwpsych&jwd=000020108236&jspc=P [accessed]
• Wright DF, Winter HR, Duffull SB (2011) Understanding the time course of pharmacological effect: a PKPD approach. Br J Clin Pharmacol 71(6):815–823. https://doi.org/10.1111/j.1365-2125.2011.03925.x
  Article CAS PubMed PubMed Central Google Scholar
• Yamanaka Y (1982) Effects of brain biogenic amines on ethanol withdrawal reactions and the development of ethanol dependence in mice. Jpn J Pharmacol 32(3):499–508. https://doi.org/10.1254/jjp.32.499
  Article CAS PubMed Google Scholar
• Yamanaka Y, Egashira T (1982) Effects of ethanol on catecholamine levels and related enzyme activities in different brain regions of rats. Jpn J Pharmacol 32(4):599–606. https://doi.org/10.1254/jjp.32.599
  Article CAS PubMed Google Scholar